Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVKD Cadrenal Therapeutics, Inc.

交易中 12-15 11:42:43 EST

12.05

+1.05

+9.55%

最高12.50	最低10.92	成交量11.26万
今开11.82	昨收11.00	日振幅14.37%
总市值2,501万	流通市值1,861万	总股本207.58万
成交额133.99万	换手率7.29%	流通股本154.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":12.05,"timestamp":1765816959069,"preClose":11,"halted":0,"volume":112600,"delay":0,"floatShares":1544500,"shares":2075845,"eps":-8.615186,"marketStatus":"交易中","change":1.05,"latestTime":"12-15 11:42:43 EST","open":11.82,"high":12.5,"low":10.9189,"amount":1339854.5366,"amplitude":0.143736,"askPrice":12.2,"askSize":200,"bidPrice":12.14,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.615186,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1674190800000,"exchange":"NASDAQ","adjPreClose":11,"preHourTrading":{"tag":"盘前","latestPrice":11.93,"preClose":11,"latestTime":"09:29 EST","volume":1614,"amount":19004.927472,"timestamp":1765808999122},"postHourTrading":{"tag":"盘后","latestPrice":11,"preClose":11,"latestTime":"19:30 EST","volume":120,"amount":1343.97,"timestamp":1765585839737},"volumeRatio":4.020521},"requestUrl":"/m/hq/s/CVKD/wiki","defaultTab":"wiki","newsList":[{"id":"1198648709","title":"Cadrenal Therapeutics, Inc. - Veralox在未来商业化时有权获得收购资产全球销售的特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1198648709","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198648709?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:07","pubTimestamp":1765458440,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics, Inc. - Veralox在未来商业化时有权获得收购资产全球销售的特许权使用费","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"gpt_icon":0},{"id":"1164645722","title":"Cadrenal Therapeutics收购Vlx-1005，首个2期12-Lox抑制剂，针对肝素诱导的血小板减少症（Hit）患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1164645722","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164645722?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:07","pubTimestamp":1765458427,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics收购Vlx-1005，首个2期12-Lox抑制剂，针对肝素诱导的血小板减少症（Hit）患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"gpt_icon":0},{"id":"2586294705","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘急速下挫5.44%报9.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586294705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586294705?lang=zh_cn&edition=full","pubTime":"2025-11-27 03:38","pubTimestamp":1764185893,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日03时38分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速下跌5.44%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Pasithea Therapeutics Corp.涨幅较大，Scisparc Ltd.、Pasithea Therapeutics Corp.、Kala Bio, Inc.较为活跃，换手率分别为3066.29%、1736.74%、212.17%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Pasithea Therapeutics Corp.，振幅分别为285.36%、232.70%、170.86%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc正在开发其候选药物tecarfarin，以满足抗凝治疗中尚未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127033813a7138c46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127033813a7138c46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"1175022091","title":"Cadrenal Therapeutics通过收购Exithera的XIa因子抑制剂产品组合加强抗凝血管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1175022091","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175022091?lang=zh_cn&edition=full","pubTime":"2025-09-15 20:04","pubTimestamp":1757937880,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics通过收购Exithera的XIa因子抑制剂产品组合加强抗凝血管线","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"gpt_icon":0},{"id":"2560114535","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560114535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560114535?lang=zh_cn&edition=full","pubTime":"2025-08-20 02:58","pubTimestamp":1755629921,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日02时58分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅拉升5.07%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.00%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、X4制药涨幅较大，Tnf Pharmaceuticals, Inc.、Soligenix, Inc.、X4制药较为活跃，换手率分别为172.17%、121.67%、75.38%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为133.00%、55.59%、50.00%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc正在开发其候选药物tecarfarin，以满足抗凝治疗中尚未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820025841975222f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820025841975222f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CVKD","BK4539"],"gpt_icon":0},{"id":"2518240132","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大跌5.04%报16.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518240132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518240132?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613715,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速跳水5.04%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213515a26a2622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213515a26a2622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CVKD"],"gpt_icon":0},{"id":"2516658719","title":"Cadrenal Therapeutics, Inc.盘中异动 快速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658719?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:54","pubTimestamp":1741017248,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时54分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速下跌5.14%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235408989a24c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235408989a24c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2514320236","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨5.12%报19.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320236?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753102,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速上涨5.12%。截至发稿，该股报19.35美元/股，成交量1510股，换手率0.08%，振幅0.00%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223142989679a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223142989679a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CVKD"],"gpt_icon":0},{"id":"2514892503","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速上涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514892503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514892503?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:18","pubTimestamp":1740669507,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时18分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速上涨5.49%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723182798951a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723182798951a89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CVKD"],"gpt_icon":0},{"id":"2514263854","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514263854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514263854?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:34","pubTimestamp":1740584097,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时34分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速拉升5.16%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226233457a25505c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226233457a25505c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2512611411","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘大幅拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512611411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512611411?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:41","pubTimestamp":1739893303,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时41分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.16%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218234143988a0ac9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218234143988a0ac9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CVKD","LENZ","BK4139"],"gpt_icon":0},{"id":"2510686328","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.08%报17.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510686328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510686328?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197869,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速下挫5.08%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223110961dffb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223110961dffb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CVKD"],"gpt_icon":0},{"id":"2509299887","title":"Cadrenal Therapeutics, Inc.盘中异动 临近午盘大幅下跌5.13%报18.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509299887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509299887?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:48","pubTimestamp":1738946938,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时48分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速下跌5.13%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004858abc648e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004858abc648e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CVKD"],"gpt_icon":0},{"id":"2509778979","title":"Cadrenal Therapeutics, Inc.盘中异动 快速下挫5.27%报18.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509778979?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:50","pubTimestamp":1738875013,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时50分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速跳水5.27%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045013987cc3c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045013987cc3c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2506517844","title":"Cadrenal Therapeutics, Inc.盘中异动 大幅跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506517844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506517844?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:20","pubTimestamp":1738077602,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时20分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速跳水5.33%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282320029875713c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282320029875713c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CVKD"],"gpt_icon":0},{"id":"2505269347","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨6.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505269347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505269347?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:36","pubTimestamp":1737556569,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时36分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速拉升6.26%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223609986f7877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223609986f7877&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CVKD"],"gpt_icon":0},{"id":"2505204639","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨6.32%报18.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505204639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505204639?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:12","pubTimestamp":1737479534,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时12分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速上涨6.32%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.82%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122011214abb369ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122011214abb369ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","LENZ","BK4007"],"gpt_icon":0},{"id":"2503679278","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘急速拉升5.57%报16.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503679278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503679278?lang=zh_cn&edition=full","pubTime":"2025-01-16 03:38","pubTimestamp":1736969915,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日03时38分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速拉升5.57%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.53%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116033835a2234410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116033835a2234410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CVKD","BK4007"],"gpt_icon":0},{"id":"2503583147","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌6.82%报15.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503583147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503583147?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:46","pubTimestamp":1736779592,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时46分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速下挫6.82%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132246329864d8d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132246329864d8d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2501776918","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大跌6.28%报16.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501776918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501776918?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:13","pubTimestamp":1736349229,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时13分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下挫6.28%。截至发稿，该股报16.72美元/股，成交量9996股，换手率0.56%，振幅7.06%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108231349a21a5ddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108231349a21a5ddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","LENZ","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cadrenal.com","stockEarnings":[{"period":"1week","weight":0.0806},{"period":"1month","weight":-0.1013},{"period":"3month","weight":-0.1635},{"period":"6month","weight":-0.2063},{"period":"1year","weight":-0.0517},{"period":"ytd","weight":-0.2409}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cadrenal Therapeutics, Inc.于2022年1月25日注册为特拉华州公司。该公司正在开发公司候选药物替卡法林，用于抗凝治疗方面未满足的需求。替卡法林是一种晚期新型口服和可逆抗凝血剂（血液稀释剂），用于预防心脏病发作、中风，以及需要慢性抗凝的罕见心血管疾病患者因血栓而死亡。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.912091},{"month":2,"riseRate":0,"avgChangeRate":-0.312103},{"month":3,"riseRate":0,"avgChangeRate":-0.165695},{"month":4,"riseRate":0,"avgChangeRate":-0.132322},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.019116},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.011801},{"month":7,"riseRate":0,"avgChangeRate":-0.216246},{"month":8,"riseRate":0.666667,"avgChangeRate":0.106371},{"month":9,"riseRate":0.666667,"avgChangeRate":0.247631},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040335},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.124766},{"month":12,"riseRate":0.666667,"avgChangeRate":0.244718}],"exchange":"NASDAQ","name":"Cadrenal Therapeutics, Inc.","nameEN":"Cadrenal Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cadrenal Therapeutics, Inc.,CVKD,Cadrenal Therapeutics, Inc.股票,Cadrenal Therapeutics, Inc.股票老虎,Cadrenal Therapeutics, Inc.股票老虎国际,Cadrenal Therapeutics, Inc.行情,Cadrenal Therapeutics, Inc.股票行情,Cadrenal Therapeutics, Inc.股价,Cadrenal Therapeutics, Inc.股市,Cadrenal Therapeutics, Inc.股票价格,Cadrenal Therapeutics, Inc.股票交易,Cadrenal Therapeutics, Inc.股票购买,Cadrenal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}